Verily, an Alphabet company, today announced the appointment of Lisa Greenbaum to the newly-created role of chief revenue officer. Greenbaum will be responsible for all commercial activities across the organization including sales, business development, alliance management, sales operations and other sales-related activities and teams. Greenbaum’s appointment builds upon Verily’s January 2021 appointment of Andreas “Drew” Panayiotou as chief marketing officer.
“This is an exciting time at Verily as we continue to build out our commercial capabilities to advance innovative, impactful solutions across healthcare,” said Stephen Gillett, chief operating officer of Verily. “We are excited to welcome Lisa who brings more than 25 years of commercial and business development experience to Verily. She will be a strong complement to Drew and the rest of the team as we prepare for the next stages of our growth and evolution into a sustainable, multi-product, next-generation healthcare company.”
“Verily’s commitment to pushing scientific boundaries to advance patient-driven healthcare solutions represents a unique and compelling opportunity,” said Greenbaum. “I am excited to join the team as they continue to build a robust commercial organization and look forward to applying my experience and expertise to help maximize the value that Verily can bring to patients, employers, hospital systems, and pharmaceutical and medical device manufacturers in need of new healthcare solutions.”
About Lisa Greenbaum, Chief Revenue Officer
Lisa Greenbaum is the chief revenue officer at Verily, where she is responsible for all commercial activities across the organization including sales, business development, alliance management, and sales operations. Prior to Verily, Lisa was chief client officer at Progyny where she led sales, account management, and channel partnerships. She joined Progyny prior to the IPO and was a key contributor to the company’s growth during her tenure. Before Progyny, Lisa spent 15 years at WebMD where she was group general manager of Medscape Professional Services and led sales, account management, product marketing and revenue delivery. Lisa has also held senior sales roles in the pharmaceutical and digital health space at HealthStream, Merck, and Procter & Gamble. She holds a bachelor’s degree from Duke University.
About Drew Panayiotou, Chief Marketing Officer
Andreas “Drew” Panayiotou is the chief marketing officer at Verily where he is responsible for all brand, digital and product marketing efforts, as well as overall marketing operations. Drew is currently an advisory board member to Swire Coca-Cola USA, one of the country’s largest beverage companies. He brings more than 28 years of experience in global leadership roles with leading brands including Johnson & Johnson, Hershey’s, The Coca-Cola Company, Best Buy, The Walt Disney Company and BBDO. Previously, Drew was President of Red Wagon Ventures within Chick-fil-A where he led the development of new retail concepts and growth platforms. In his career he has been at the center of innovation advancing the new platforms, including the Disney MagicBand and the Best Buy Media Network. Drew graduated summa cum laude from Boston College, and received his MBA in Marketing and degree in Health Sector Management at Duke University, where he was a Fuqua Scholar.
Launched in 2015, Verily is a subsidiary of Alphabet focused on life sciences and healthcare. Verily’s mission is to make the world’s health data useful so that people enjoy healthier lives. Verily develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage disease. Verily partners with leading life sciences, medical device, and government organizations, using deep hardware, software, scientific, and healthcare expertise to enable faster development, meaningful advances, and deployment at scale. For more information, please visit www.verily.com.